Vismodegib: First-in-Class Hedgehog Pathway Inhibitor for Metastatic or Locally Advanced Basal Cell Carcinoma.
about
Neglected skin cancer in the elderly: a case of basosquamous cell carcinoma of the right shoulder.Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma.Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets.
P2860
Vismodegib: First-in-Class Hedgehog Pathway Inhibitor for Metastatic or Locally Advanced Basal Cell Carcinoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Vismodegib: First-in-Class Hed ...... Advanced Basal Cell Carcinoma.
@ast
Vismodegib: First-in-Class Hed ...... Advanced Basal Cell Carcinoma.
@en
type
label
Vismodegib: First-in-Class Hed ...... Advanced Basal Cell Carcinoma.
@ast
Vismodegib: First-in-Class Hed ...... Advanced Basal Cell Carcinoma.
@en
prefLabel
Vismodegib: First-in-Class Hed ...... Advanced Basal Cell Carcinoma.
@ast
Vismodegib: First-in-Class Hed ...... Advanced Basal Cell Carcinoma.
@en
P2093
P2860
P1476
Vismodegib: First-in-Class Hed ...... Advanced Basal Cell Carcinoma.
@en
P2093
Makeda Walker
Nancy M Nix
Olivia Burdine
P2860
P304
P356
10.6004/JADPRO.2014.5.4.7
P577
2014-07-01T00:00:00Z